Histone deacetylase inhibitor for NUT midline carcinoma.

Maher, Ossama M; Christensen, Anthony M; Yedururi, Sireesha; Bell, Diana; Tarek, Nidale

Maher, Ossama M; Christensen, Anthony M; Yedururi, Sireesha; Bell, Diana; Tarek, Nidale.

Affiliation

Maher OM; Department of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, Texas; Department of Pediatrics, National Cancer Institute, Cairo University, Cairo, Egypt.

Pediatr Blood Cancer ; 62(4): 715-7, 2015 Apr.

Article in En | MEDLINE | ID: mdl-25557064

Subject(s)

Carcinoma/drug therapy; Histone Deacetylase Inhibitors/administration & dosage; Hydroxamic Acids/administration & dosage; Mandibular Neoplasms/drug therapy; Pleural Effusion, Malignant/drug therapy; Adolescent; Carcinoma/diagnosis; Carcinoma/pathology; Female; Humans; Mandibular Neoplasms/diagnosis; Mandibular Neoplasms/pathology; Neoplasm Metastasis; Pleural Effusion, Malignant/diagnosis; Pleural Effusion, Malignant/pathology; Vorinostat

Key words

NUT midline carcinoma; histone deacetylase inhibitor

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Mandibular Neoplasms / Pleural Effusion, Malignant / Histone Deacetylase Inhibitors / Hydroxamic Acids Type of study: Diagnostic_studies Limits: Adolescent / Female / Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2015 Type: Article Affiliation country: Egypt

Fulltext

XML

PubMed Links

Search on Google